+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-mutant diphtheria toxin vaccines

Multi-mutant diphtheria toxin vaccines

Official Gazette of the United States Patent & Trademark Office Patents 1262(4), Sep 24

Disclosed are diphtheria toxin polypeptides having multiple mutations, which render the polypeptides useful as vaccines.

(PDF 0-2 workdays service: $29.90)

Accession: 035349374

Download citation: RISBibTeXText

Related references

Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin. Journal of Biochemistry 142(1): 105-112, 2007

Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines. Vaccine 34(11): 1405-1411, 2016

Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin. Infection and Immunity 69(2): 869-874, 2001

Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications. Biologicals 39(4): 195-204, 2011

Diphtheria toxin and related proteins part 3 reconstitution of hybrid diphtheria toxin from nontoxic mutant proteins. Journal of Biological Chemistry 248(11): 3851-3854, 1973

Diphtheria toxin and related proteins. 3. Reconstitution of hybrid "diphtheria toxin" from nontoxic mutant proteins. Journal of Biological Chemistry 248(11): 3851-3854, 1973

Induction of oral tolerance to diphtheria toxin by feeding mice with formalinized diphtheria nontoxic mutant CRM197. FASEB Journal 12(4): A599, March 17, 1998

Vibrio cholerae O139 conjugate vaccines: Synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infection & Immunity 68(9): 5037-5043, September, 2000

Diphtheria toxin and related proteins part 1 isolation and properties of mutant proteins serologically related to diphtheria toxin. Journal of Biological Chemistry 248(11): 3838-3844, 1973

Mutant with diphtheria toxin receptor and acidification function but defective in entry of toxin. Experimental Cell Research 172(1): 54-64, 1987

Formation of a hybrid toxin from ricin agglutinin and a nontoxic mutant protein of diphtheria toxin. Biochemical and Biophysical Research Communications 81(2): 268-273, 1978

Multi correlation analyses of toxic and antigenic components of diphtheria pertussis tetanus and diphtheria pertussis vaccines produced in japan. Japanese Journal of Medical Science & Biology 32(5): 295-304, 1979

Highly purified mutant E112K of cholera toxin elicits protective lung mucosal immunity to diphtheria toxin. Vaccine 20(5-6): 756-762, 12 December, 2001